Oncology -- DeltaHealth Group

Department Introduction Packages

Oncology

The department of Oncology of DeltaHealth Hospital is established by Professor Zhao Heng, Honorary Chief of Thoracic Department in Thoracic Hospital Affiliated to Shanghai Jiao Tong University, PhD ，M.M supervisor), and collaborated by a number of well-known oncology experts. It adopts international standard and technology in treating a wide spectrum of oncological diseases. It is a comprehensive diagnosis and treatment center includes surgery, chemotherapy, radiation therapy, intervention(in preparation), immune therapy, and targeted medication therapy.

The department, composed of a professional medical expert team that are well-known internationally, provides high quality medical services. With advanced disease management notion, a variety of treatment options are available for patients, leveraging the international standard of clinical diagnosis and treatment practice and cutting-edge research results. In particular, it provides MDT for lung cancer, digestive system cancer, thyroid cancer, breast cancer and other common oncology diseases. It adopts chemotherapies including neoadjuvant chemotherapy, concurrent chemoradiotherapy, adjuvant chemotherapy with the interventional treatment to carry out highly difficulty puncture biopsy and various interventional embolization treatments, so as to provide high-quality medical services for the early, middle and advanced stage patients.

Treatable Diseases：Lung cancer, Digestive system Cancer, Thyroid cancer, Breast cancer and other common oncology diseases

Key Physician Leaders

Liyan Jiang

Chief Physician

M.D.

Mandarin

Introduction：Liyan Jiang, chief physician of respiratory medicine of Chest Hospital affiliated to Shanghai Jiaotong University. She has more than 30 years of research and clinical experience in diagnosis and treatment of lung cancer. She has been dedicated to research of translational medicine of lung cancer. She is apt at diagnosis, differential diagnosis and MDT treatment of lung cancer. She has acquired national funding for multiple academic research, published more than 100 original papers and reviews, 80+ of which are published on SCI journals. She is the chief editor or editor of 7 monogragh within the discipline, including Lung Cancer, Biological Targeted Immunotherapy of Tumors, Cell Biology and Molecular Biology of Respiratory Diseases. She has won multiple Shanghai Science and Technology Achievement Awards. She is Chief of Lung Cancer Translational Medical Research Office of Shanghai Respiratory Disease Research Institute, Deputy Chief of Shanghai Chest Hospital Pharmaceutical Clinical Trial Institute, member of UICC Chest Tumor Staging Committee, Vice President of Chinese Medical Education Association, Chairwoman of Lung Tumor Professional Committee under Chinese Medical Education Association, Member of Lung Cancer Group of Respiratory Branch under Chinese Medical Association, Standing Member of Respiratory Disease Combined TCM and Western Medicine Expert Committee of Chinese Medical Doctor Association, Vice Chairwoman of Respiratory Endoscopy Expert Committee of Shanghai Anti-cancer Association, Editor of Chinese Lung Cancer Book of 《ANNOUNAL OF ONCOLOGY》,Editor of Shanghai Lung Cancer Magazine, Deputy Editor-in-Chief of Shanghai Chest and Editor and Reviewer of multiple Chinese and oversea journals.